Shao Xiao-Dong, Qi Xing-Shun, Guo Xiao-Zhong
Department of Gastroenterology, General Hospital of Shenyang Military Area Command, Shenyang, China.
Saudi J Gastroenterol. 2017 May-Jun;23(3):150-160. doi: 10.4103/1319-3767.207713.
BACKGROUND/AIMS: The aim of this study was to evaluate the effectiveness and safety of endoscopic retrograde cholangiopancreatography with double balloon enteroscope (DBE-ERCP) in patients with altered gastrointestinal anatomy in a meta-analysis.
A comprehensive literature search was conducted on PubMed, EMBASE, and Cochrane library covering the period from January 2001 to December 2015. Data were selected and abstracted from eligible studies and were pooled using a random-effects model. Heterogeneity was assessed using the I2 test.
Ten studies involving a total of 301 patients were included in the analysis. The pooled enteroscopy, diagnostic, and therapeutic success rates were 89.75% [95% confidence interval (CI): 79.65-94.30%], 79.92% (95% CI: 68.06-89.59%), and 63.55% (95% CI: 53.70-72.86%), respectively. DBE-ERCP-related complications occurred in 18 patients including perforation (5), pancreatitis (3), cholangitis (9), and bleeding (1). The incidence of DBE-ERCP-related complication was 6.27% (95% CI: 2.61-11.38%).
Diagnostic and therapeutic DBE-ERCPs are feasible in patients with altered gastrointestinal anatomy. DBE-ERCP may be considered when pancreaticobiliary diseases occur in patients undergoing Roux-en-Y reconstruction or pancreaticoduodenectomy.
背景/目的:本荟萃分析旨在评估双气囊小肠镜逆行胰胆管造影术(DBE-ERCP)在胃肠道解剖结构改变患者中的有效性和安全性。
对PubMed、EMBASE和Cochrane图书馆进行了全面的文献检索,涵盖2001年1月至2015年12月期间。从符合条件的研究中选择并提取数据,并使用随机效应模型进行汇总。使用I2检验评估异质性。
分析纳入了10项研究,共301例患者。汇总的小肠镜检查成功率、诊断成功率和治疗成功率分别为89.75%[95%置信区间(CI):79.65-94.30%]、79.92%(95%CI:68.06-89.59%)和63.55%(95%CI:53.70-72.86%)。18例患者发生了DBE-ERCP相关并发症,包括穿孔(5例)、胰腺炎(3例)、胆管炎(9例)和出血(1例)。DBE-ERCP相关并发症的发生率为6.27%(95%CI:2.61-11.38%)。
诊断性和治疗性DBE-ERCP在胃肠道解剖结构改变的患者中是可行的。对于接受Roux-en-Y重建或胰十二指肠切除术的患者发生胰胆疾病时,可考虑使用DBE-ERCP。